Skip to main content
. 2016 Dec 8;6:38466. doi: 10.1038/srep38466

Table 2. Number of cII mutations (%) detected in liver tissues from PFOS exposed λ transgenic medaka.

Mutation Spectrum PFOS (μg/L)
0a 6.7b 27.6a,c 87.6b,c
Total mutations 46 49 48 44
Independent mutations 33 36 38 41
Transition 14 (42.4) 8 (22.2) 11 (28.9) 9 (22.0)
G/C→A/T 6 (18.2) 4 (11.1) 8 (21.1) 6(14.6)
A/T→G/C 8 (24.2) 4 (11.1) 3(7.9) 3(7.3)
Transversion 15 (45.5) 23 (63.9) 20 (55.3) 20 (48.8)
G/C→T/A 5 (15.2) 10 (27.8) 12 (31.6) 8 (19.5)
G/C→C/G 3 (9.1) 11 (30.6) 3 (7.9) 4 (9.8)
T/A→A/T 1 (3.0) 0 (0.0) 3 (7.9) 5 (12.2)
A/T→C/G 6 (18.2) 2 (5.6) 2 (5.3) 3 (7.3)
Frameshift 3 (9.1) 2 (5.6) 7 (18.4) 10 (24.4)
+1 0 (0.0) 2 (5.6) 5 (13.2) 6 (14.6)
−1 3 (9.1) 0 (0.0) 2 (5.3) 1 (2.4)
Indel* 0 (0.0) 0 (0.0) 0 (0) 3 (7.3)
Other** 1 (3.0) 3 (8.3) 0 (0.0) 2 (4.9)

a,b,cTreatment groups sharing the same superscript letter are not significant different from each other based on the Monte Carlo method of Adams and Skopek.

*Frameshift caused by multi-base insertion and deletion.

**Multiplex single base substitutions at different nucleotides.

Values underlined indicate significant difference from the control group based on the Pearson’s chi-squared test (P < 0.05).